The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
Rise in prevalence of ulcerative colitis and Crohn's disease, growing awareness of the disease across the world, drives the growth of the market David Correa Allied Market Research + 1 800-792-5285 ...
The method could be used to develop a blood test to identify inflammatory-bowel-disease patients most at risk.
Scientists from the Institute of Cancer Research (ICR) have found a new method for predicting bowel cancer risk in ...
Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
Scientists from the Institute of Cancer Research (ICR), London, UK, have developed an algorithm that can predict whether ...
A NEW method for detecting bowel cancer is more than 90 per cent accurate at predicting which higher risk people will develop ...
The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.
Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...
Eight ways to reduce your risk of bowel cancer - Around half of all bowel cancers could be prevented by having a healthier ...
A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as colorectal cancer, in the five years.